Easom Eric

Easom Eric is listed in filings as Chief Executive Officer at AN2 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including purchase activity. Recent filings connect the profile to AN2 Therapeutics, Inc. (ANTX). The current snapshot covers public activity from Nov 18, 2024 to Mar 23, 2026. Reported amounts are shown as $50.0K to $10.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.